The PeerLINC Knowledge Hub hosted a weeklong capacity-building program for Bangladesh’s National Tuberculosis Program (NTP) managers to equip national leaders with the tools and knowledge to speed up the rollout of six-month BPaLM/BPaL regimens. Among the attendees was Dr. Khaled Bin Yousef, Director of Programmes at FTTC implementing partner, Nari Maitree.

Papua New Guinea (PNG) has begun rolling out the six-month, WHO-endorsed BPaL/M treatment regimens for DR-TB. This change is expected to improve treatment experiences and outcomes, and save money.

25% price reduction of key DR-TB drug, pretomanid, announced by TB Alliance, Lupin Limited, and Stop TB Partnership’s Global Drug Facility (GDF). Pretomanid price falls below $1 per day; BPaLM price falls below $2 per day.